Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma

Journal article

Peer reviewed

Gary Ulaner, Nicholas Sobol, Joe O'Donoghue, Serge Lyashchenko, Jason Lewis and C. Ola Landgren

Clinical lymphoma, myeloma and leukemia, Vol.19(10), pp.e19-e19

2019-10

Metrics

5 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma
Creators: Gary Ulaner - Memorial Sloan Kettering Cancer Center
Nicholas Sobol - Memorial Sloan Kettering Cancer Center
Joe O'Donoghue - Memorial Sloan Kettering Cancer Center
Serge Lyashchenko - Memorial Sloan Kettering Cancer Center
Jason Lewis - Memorial Sloan Kettering Cancer Center
C. Ola Landgren - Memorial Sloan Kettering Cancer Center
Publication Details: Clinical lymphoma, myeloma and leukemia, Vol.19(10), pp.e19-e19
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Department of Medicine
Language: English
Resource Type: Journal article
Record Identifier: 991031713360402976